A graduate of LSU School of Medicine, Dr
The shortages arent just affecting the U.S.: The European Medicines Agency warned the GLP-1 drug shortage is a major public health concern that probably wont be resolved in 2024
Anyway, heres what went down across MAHA, price transparency, and potential Medicaid cuts: On February 13th , after RFKs nomination, an executive order officially established the MAHA movement
GLP-1 receptor agonist effects on lipid and liver profiles in patients with nonalcoholic fatty liver disease: systematic review and meta-analysis
Health-related quality of life is significantly impaired across all fibrosis stages, with impairments intensifying with disease severity
Start your weight loss journey with prescription Semaglutide or Tirzepatide from board-certified physicians.Start Your Free AssessmentHow It WorksComplete Free Assessment Fill out a 5-minute online health questionnaire available 24/7.Physician Review A board-certified doctor reviews your assessment within 224 hours on average.Prescription & Payment Receive your personalized treatment plan
